[1]张红新.归脾汤联合美托洛尔治疗冠心病合并心律失常的效果及预后[J].医学信息,2019,32(04):156-157.[doi:10.3969/j.issn.1006-1959.2019.04.051]
　ZHANG Hong-xin.Effect and Prognosis of Guipi Decoction Combined with Metoprolol in the Treatment of Coronary Heart Disease Complicated with Arrhythmia[J].Journal of Medical Information,2019,32(04):156-157.[doi:10.3969/j.issn.1006-1959.2019.04.051]
点击复制

归脾汤联合美托洛尔治疗冠心病合并心律失常的效果及预后()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年04期
页码:
156-157
栏目:
中医中药
出版日期:
2019-02-15

文章信息/Info

Title:
Effect and Prognosis of Guipi Decoction Combined with Metoprolol in the Treatment of Coronary Heart Disease Complicated with Arrhythmia
文章编号:
1006-1959（2019）04-0156-02
作者:
张红新
（天津市武清区人民医院中医科，天津 301700）
Author(s):
ZHANG Hong-xin
(Department of Traditional Chinese Medicine,People's Hospital of Wuqing District,Tianjin 301700, China)
关键词:
美托洛尔; 冠心病; 心律失常; 归脾汤
Keywords:
Metoprolol; Coronary heart disease; Arrhythmia; Guipi Decoction
分类号:
R541.4；R541.7
DOI:
10.3969/j.issn.1006-1959.2019.04.051
文献标志码:
A
摘要:
目的 观察美托洛尔治疗冠心病合并心律失常中辅以归脾汤的效果及预后。方法 选取2017年6月~2018年6月我院收治的冠心病合并心律失常患者110例，将其随机分为对照组和观察组，每组55例。对照组给予美托洛尔治疗，观察组在对照组治疗基础上辅以归脾汤治疗。比较两组临床疗效、24 h心律失常发生率、室性早搏次数以及不良反应发生率。结果 观察组治疗总有效率为96.36%，高于对照组的78.18%，差异有统计学意义（P＜0.05）；观察组24 h心律失常发生率、室性早搏次数均低于对照组，差异有统计学意义（P＜0.05）；观察组不良反应发生率为7.27%，低于对照组的12.72%，差异无统计学意义（P＞0.05）。结论 临床治疗冠心病合并心律失常中在美托洛尔的基础上辅以归脾汤，可以有效改善患者临床症状，且不良反应少、治疗效果更显著，值得临床借鉴应用。
Abstract:
Objective To observe the effect and prognosis of metoprolol in the treatment of coronary heart disease complicated with arrhythmia with Guipi Decoction. Methods A total of 110 patients with coronary heart disease and arrhythmia admitted to our hospital from June 2017 to June 2018 were randomly divided into control group and observation group, 55 cases in each group. The control group was treated with metoprolol. The group was treated with Guipi Decoction on the basis of the treatment of the control group. The clinical efficacy, 24 h arrhythmia, ventricular premature beats and adverse reactions were compared between the two groups. Results The total effective rate of the observation group was 96.36%, which was higher than that of the control group 78.18%,the difference was statistically significant (P<0.05).The incidence of arrhythmia and ventricular premature beats in the observation group were lower than those in the control group at 24 h (P<0.05). The incidence of adverse reactions in the observation group was 7.27%, which was lower than that in the control group 12.72%,the difference was not statistically significant (P>0.05). Conclusion Clinical treatment of coronary heart disease with arrhythmia combined with metoprolol supplemented with Guipi Decoction can effectively improve the clinical symptoms of patients, and the adverse reactions are less, the treatment effect is more significant, it is worthy of clinical application.

参考文献/References:


[1]李小静,侯俊杰.冠心病慢性心力衰竭患者室性心律失常临床治疗分析[J].中国现代药物应用,2015,9(22):162-163.
[2]韦璎洛,曹红,黄从新,等.稳心颗粒联合美托洛尔治疗冠心病合并室性心律失常的系统评价[J].海南医学,2014,25(5):752-757．
[3]张大勇.稳心颗粒联合美托洛尔治疗老年冠心病合并心律失常疗效观察[J].亚太传统医药,2014,10(15):111-112.
[4]中华人民共和国卫生部.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2013:68-69.
[5]王振生.归脾汤加减治疗冠心病合并心律失常的疗效观察[J].四川中医,2013,9(3):301.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
　YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Journal of Medical Information,2018,31(04):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
　ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Journal of Medical Information,2018,31(04):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]郑 磊.美托洛尔联合卡托普利对慢性心衰患者心肌重构及心功能的影响分析[J].医学信息,2018,31(03):130.[doi:10.3969/j.issn.1006-1959.2018.03.045]
　ZHENG Lei.Effect of Metoprolol Combined with Captopril on Myocardial Remodeling and Cardiac Function in Patients with Chronic Heart Failure[J].Journal of Medical Information,2018,31(04):130.[doi:10.3969/j.issn.1006-1959.2018.03.045]
[4]张 挺.厄贝沙坦联合美托洛尔治疗慢性充血性心衰的疗效观察[J].医学信息,2018,31(05):125.[doi:10.3969/j.issn.1006-1959.2018.05.044]
　ZHANG Ting.Efficacy of Irbesartan Combined with Metoprolol in the Treatment of Chronic Congestive Heart Failure[J].Journal of Medical Information,2018,31(04):125.[doi:10.3969/j.issn.1006-1959.2018.05.044]
[5]张 旭.冠心病心绞痛患者进行护理干预的临床效果及 对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
　ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Journal of Medical Information,2018,31(04):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[6]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
　XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Journal of Medical Information,2018,31(04):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[7]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
　WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Journal of Medical Information,2018,31(04):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[8]毛红岩.冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
　MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Journal of Medical Information,2018,31(04):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[9]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(04):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[10]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(04):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[11]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
　ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Journal of Medical Information,2018,31(04):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[12]纪东华.曲美他嗪治疗老年冠心病心力衰竭的疗效及其对患者 炎症因子的影响[J].医学信息,2019,32(13):141.[doi:10.3969/j.issn.1006-1959.2019.13.043]
　JI Dong-hua.Efficacy of Trimetazidine in the Treatment of Elderly Patients with Coronary Heart Disease and Its Effect on Inflammatory Factors[J].Journal of Medical Information,2019,32(04):141.[doi:10.3969/j.issn.1006-1959.2019.13.043]

更新日期/Last Update: 2019-03-07